Qi Li
Directeur/Bestuurslid bij Beijing Mabworks Biotech Co., Ltd.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Feng Li | M | 52 |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 13 jaar |
| Bo Yan Zhang | M | 59 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 jaar |
| Yiu Leung Cheung | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 jaar |
| Wen Qi Hu | M | 62 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 jaar |
| Tao Zhu | M | 51 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 jaar |
| Tian Wang | M | 33 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 jaar |
| Ren Yu Li | M | 63 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 jaar |
| Wing Sze Yu | F | 41 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Tong Li | F | 49 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 jaar |
| Tai Feng Xie | M | 66 |
Capital University of Economics & Business
| 18 jaar |
| Yuan Ju Ma | M | 67 |
Capital University of Economics & Business
| 20 jaar |
| Zhan Chao Liang | M | 40 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 8 jaar |
| Ting Li | F | 35 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 jaar |
| Jing Zhang | F | 42 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 jaar |
| Jin Jin Liang | M | 55 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 jaar |
| Hui Fang Liu | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 jaar |
| Pei Ye | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 jaar |
| Yan Qi | F | 54 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 17 jaar |
| Ru Yu Hao | M | 76 |
Capital University of Economics & Business
| 20 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Zhi Dong | M | 44 |
Capital University of Economics & Business
| 4 jaar |
| Guan Jun Zhou | M | - |
Capital University of Economics & Business
| 4 jaar |
| Yongcheng Wang | M | - |
Capital University of Economics & Business
| 1 jaar |
| Minhao Zhao | M | 40 |
Capital University of Economics & Business
| 2 jaar |
| Yong Xing Chen | M | 57 |
Capital University of Economics & Business
| 1 jaar |
| Yinuo Jiang | F | - |
Capital University of Economics & Business
| 4 jaar |
| Zheng Ting Zhao | M | 52 |
Capital University of Economics & Business
| 1 jaar |
| Wen Gang Liu | M | 44 |
Capital University of Economics & Business
| 1 jaar |
| Feng Ye | M | 63 |
Capital University of Economics & Business
| 2 jaar |
| Xing Hua Wang | M | 39 |
Capital University of Economics & Business
| 4 jaar |
| Qing Xue | F | 36 |
Capital University of Economics & Business
| 4 jaar |
| Xiao Feng Hou | M | 48 |
Capital University of Economics & Business
| 1 jaar |
| Gang Wang | M | 57 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 2 jaar |
| Min Su | F | 42 |
Capital University of Economics & Business
| 1 jaar |
| Jun Yang | M | 56 |
Capital University of Economics & Business
| 1 jaar |
| Ran Gao | F | 38 |
Capital Normal University
| 4 jaar |
| Yang Wang | M | 39 |
Capital University of Economics & Business
| 4 jaar |
| Kai Du | M | - |
Capital University of Economics & Business
| 4 jaar |
| Xiao Ni Zhang | F | 37 |
Capital Normal University
| 1 jaar |
| Bo Tian | M | 52 |
Capital University of Economics & Business
| 1 jaar |
| Mei Wang | F | 42 |
Capital University of Economics & Business
| 4 jaar |
| Chun Hong Li | F | 50 |
Capital University of Economics & Business
| 1 jaar |
| Wen Hong Li | M | 49 |
Capital University of Economics & Business
| 1 jaar |
| Lei Fu | M | 73 |
Capital University of Economics & Business
| 3 jaar |
| Chang Liu | M | - |
Capital University of Economics & Business
| 4 jaar |
| Hong Liang Guan | M | 54 |
Capital Normal University
| 3 jaar |
| Lei Han | F | 36 |
Capital University of Economics & Business
| 4 jaar |
| Xiao Wen Hu | M | 48 |
Capital University of Economics & Business
| 1 jaar |
| Xin Zhao | F | 43 |
Capital University of Economics & Business
| 1 jaar |
| Zhao Guo Luo | M | 46 |
Capital University of Economics & Business
| 1 jaar |
| Gang Ding | M | 44 |
Capital University of Economics & Business
| 4 jaar |
| Xiao juan Wang | F | - |
Capital University of Economics & Business
| 4 jaar |
| Jiang Wu | M | - |
Capital University of Economics & Business
| 1 jaar |
| Xiang Neng Wang | M | 60 |
Capital University of Economics & Business
| 2 jaar |
| Yu Jie Wang | F | 39 |
Capital University of Economics & Business
| 4 jaar |
| En Lei Zhu | M | 44 |
Capital University of Economics & Business
| 1 jaar |
| Liang Zhang | M | 47 |
Capital University of Economics & Business
| 2 jaar |
| Xiao Bin Jiang | M | 54 |
Capital University of Economics & Business
| 2 jaar |
| Yi Xin Zhao | M | 48 |
Capital University of Economics & Business
| 1 jaar |
| Lijie Hu | F | 49 |
Capital University of Economics & Business
| 2 jaar |
| Lu Liu | F | 40 |
Capital University of Economics & Business
| 4 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| China | 60 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties